This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Sacroiliac joint (SIJ) pain

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The sacroiliac joint (SIJ) is a synovial joint.

  • prevalence of sacroiliac joint pain in patients presenting with lower back pain ranges from 15% to 25%

  • SIJ pain can result from either intra-articular causes, for example arthritis or infection, or extraarticular causes, including enthesopathy, ligamentous injury, fractures ormyofascial pain

  • SIJ pain cannot be diagnosed from history or physical examination alone, and X-ray and MRI are necessary

Treatment

  • initial treatment should involve non-invasive measures such as anti-inflammatory medications and physiotherapy, focussing on exercises to improve lumbopelvic stability
  • invasive treatment, which involves injection of the SIJ, can also be used in the diagnosis of SIJ pain
    • blind injections are unreliable and not recommended
    • radiologically guided SIJ injections can provide pain relief for up to 1 year (1)
      • injections are performed under fluoroscopy or CT or MRI guidance or more recently, realtime, high-resolution ultrasound guidance.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.